Meningioma mimicking an intraparenchymal cystic tumor

Tomoaki Tamada1, Rei Enatsu1, Noriaki Kikuchi2

  • 1Department of Neurosurgery, Sapporo Medical University School of Medicine, Sapporo, Japan.

Insights

Cystic meningiomas with mural nodules are rare and can mimic intraparenchymal tumors. This case highlights the importance of considering meningioma in the differential diagnosis for such brain lesions.

Area of Science:

  • Neurosurgery
  • Neuropathology
  • Neuroradiology

Background:

  • Meningiomas are typically dural-based tumors, but cystic variants with mural nodules are uncommon.
  • These rare presentations can be mistaken for intraparenchymal cystic neoplasms on imaging.
  • Accurate preoperative diagnosis is crucial for appropriate surgical planning and patient management.

Observation:

  • A 64-year-old woman presented with a left temporal lobe cystic lesion and enhancing mural nodule, associated with peritumoral brain edema.
  • Initial differential diagnoses included low-grade gliomas and hemangioblastoma.
  • Intraoperative findings confirmed an extraparenchymal tumor with a thin membrane and yellowish cystic fluid.

Findings:

  • Pathological examination confirmed the diagnosis of microcystic meningioma, WHO grade I.
  • The imaging characteristics mimicked those of intraparenchymal tumors like hemangioblastoma and pleomorphic xanthoastrocytoma.
  • Gross total resection was successfully achieved via a temporal surgical approach.

Implications:

  • This case underscores the necessity of including meningioma in the differential diagnosis for cystic brain lesions with mural nodules.
  • Recognizing this rare presentation can prevent misdiagnosis and guide neurosurgical interventions.
  • Further awareness of cystic meningioma subtypes can improve diagnostic accuracy in neuro-oncology.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
885
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
543
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K